As medications like Ozempic and Wegovy grow in popularity, fertility specialists say that for GLP-1 pregnancy safety, planning ahead is essential for safe pregnancy and long-term health.
For many people using medications such as Ozempic, Wegovy, or Mounjaro, a new question is emerging in clinics across the United States: What happens if you want to start a family?
Doctors say the answer is becoming more urgent as GLP-1 medications grow in popularity for diabetes treatment and weight management — including among many Latino patients, who face higher rates of type 2 diabetes nationwide. Health specialists emphasize that while these medications can improve metabolic health, they are not recommended during pregnancy or when actively trying to conceive.
Guidance cited by clinicians from institutions such as San Diego Fertility Center and University Hospitals recommends stopping GLP-1 medications at least two months before attempting pregnancy. The reason is what doctors call a “washout period,” allowing the drug to fully leave the body.
Why doctors urge caution
Most safety data about GLP-1 medications and pregnancy comes from animal studies. Researchers observed potential risks to fetal development, and because human data remains limited, physicians take a precautionary approach.
Medical experts say this doesn’t mean the medications are unsafe in general — but pregnancy introduces biological changes that require careful monitoring.
“If someone becomes pregnant while taking a GLP-1 medication, the most important step is to contact their healthcare provider quickly,” clinicians often advise in reproductive health guidance shared with patients.
A complex relationship with fertility
Interestingly, specialists note that GLP-1 medications may indirectly improve fertility for some patients, especially those living with obesity or polycystic ovary syndrome (PCOS). Weight stabilization and improved insulin sensitivity can help restore ovulation in some cases.
But that improvement can sometimes surprise patients.
Across fertility clinics, doctors say they are seeing more cases where individuals did not expect to conceive while using these medications — a reminder that reproductive planning conversations should happen early.
What health experts recommend now
Reproductive endocrinologists emphasize three key steps:
• Speak with a physician before stopping medication.
• Plan a medically supervised transition if trying to conceive.
• Allow enough time — typically about two months — for the medication to clear the system.
Clinicians also stress that continuity of care matters, especially for patients managing diabetes, metabolic conditions, or hormonal disorders.
Why this conversation matters now
Public health researchers note that GLP-1 medications are reshaping weight and metabolic care in the U.S., but pregnancy guidance is still catching up with their widespread use.
For families thinking about the future, doctors say the message is simple: planning ahead with a trusted medical professional is the safest path forward.
Pertussis Vaccine During Pregnancy Protects Babies at the Point of Infection, Study Finds
